Omnicell Showcases Latest Advancements to Medication Management Portfolio at Arab Health Exhibition and Congress

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, today announced the Company will be showcasing the latest advancements to its medication management portfolio at the Arab Health Exhibition and Congress from 27-30 January in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the Middle East region.

According to a report by Colliers International, healthcare spending in Saudi Arabia alone has grown at a compound annual growth rate of 12.1 percent over the last nine years, and is expected to increase to US$160 billion by 2030. Omnicell's solution portfolio supports the vision of autonomous pharmacy, a roadmap designed to improve patient outcomes and operational efficiencies while helping to reduce cost through a series of autonomous and digital workflows, powered by a cloud data platform.

The autonomous pharmacy vision integrates solutions across three key areas. These will be showcased in Hall 3, Stand J30 during the Exhibition and Congress:

• Automation ? innovative solutions designed to digitize and streamline workflows across the continuum of care. Omnicell's platform of automation solutions supports medication safety on patient wards; provides more efficient medication storage, dispensing, and filling in the hospital pharmacy; and helps improve medication adherence through automated multimed packaging solutions for outpatient pharmacy, which can result in better patient outcomes.

• Intelligence ? predictive intelligence that provides actionable insights to better understand medication usage and improve pharmacy supply chain management. Omnicell solutions offer flexibility to manage supplies anywhere in the hospital through enhanced tracking, usage capture and visibility to help reduce stock outs or over-ordering inventory.

• Expert Services ? an extension of pharmacy operations to support improved efficiency and enhanced patient care. These services can help deliver an accelerated time-to-value for implementation projects and greater achievement of anticipated outcomes.

"At Omnicell, we recognize the risk and cost associated with manual, inefficient processes," said Arthur Van Dongen, vice president and general manager, International at Omnicell. "We are committed to delivering the technology and tools that will automate these processes, ultimately helping our hospital partners achieve their operational, financial, and clinical outcomes."

About Omnicell

Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and expert services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Over 6,000 facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 40,000 institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.

OMCL-G